Applications of D-Luciferin Sodium Salt in Industrial Manufacturing

D-Luciferin Sodium Salt functions as an essential luminescent substrate for a range of biotechnology and pharmaceutical applications requiring precise bioluminescence detection. As a primary manufacturer, we serve multiple advanced industrial segments, each demanding strict process standards and material performance.

1. High-Throughput Screening in Drug Discovery

Pharmaceutical R&D facilities integrate D-Luciferin Sodium Salt in high-throughput screening workflows to measure gene expression, cell viability, and compound activity via luciferase-expressing assay platforms. Automated liquid handling systems incorporate the substrate post assay incubation, supporting sensitive detection for enzyme and receptor interaction studies, and accelerating lead compound identification. Formulation of luciferin reagents adheres to consistency, stability, and solubility requirements at large scale, guaranteeing reproducible signal kinetics and minimal occurrence of background luminescence interference.

Industry compliance standards

• USP General Chapter <1040> Biotechnology-Derived Articles
• ICH Q7 GMP for Active Pharmaceutical Ingredients
• 21 CFR Part 211 (FDA Good Manufacturing Practice)
• ISO 13485 Quality Management for Medical Devices (applicable to in vitro diagnostic kits)

Typical usage ratio

• 100–300 μg/mL working solution, optimized per luciferase cell line sensitivity and assay format
• Adjustment based on microplate throughput (e.g., 96 vs. 384 wells), signal duration, and detection system

Downstream process integration

• Substrate prepared in sterile buffer and dispensed before luminescence reading phase
• Used after cell plating and compound exposure stages
• Solution often incorporated by automated pipetting modules for multi-well format compatibility

Final product types

• Ready-to-use luminescent cell-based assay kits
• Pharmaceutical compound screening kits
• Preformulated reporter gene detection reagents
• Automated luciferase high-throughput platforms

2. In Vivo Imaging Reagent Production

Biomedical imaging suppliers use D-Luciferin Sodium Salt in the formulation of injectable solutions for small animal research. The substrate enables real-time non-invasive monitoring of gene expression and tumor progression in live animal models expressing luciferase. Manufacturers require precise solubility control, endotoxin-free raw materials, and compatibility with in vivo grade sterile filtration. Strict process validation ensures reduced batch variability and consistent in vivo bioluminescent output.

Industry compliance standards

• European Pharmacopoeia 2.6.14 (Bacterial Endotoxins)
• 21 CFR 610 (General Biological Products Standards)
• ISO 9001:2015 Quality Management Systems
• Animal Welfare Act compliance for downstream imaging services

Typical usage ratio

• 15–150 mg/kg body weight for rodent imaging studies
• Solubility adjusted to 7.5–30 mg/mL in physiological buffer based on injection volume and imaging window

Downstream process integration

• Raw material dissolved in pyrogen-free buffer and sterile-filtered
• Aliquoted into injectable vials under aseptic conditions
• Distributed to animal facilities or academic research labs for direct administration

Final product types

• Sterile injectable luciferin vials for in vivo imaging
• Multi-dose bioluminescent imaging kits
• Custom luciferase substrate formulations for preclinical CROs
• Pre-filled syringes for rapid animal model screening

3. Clinical Diagnostic Test Kit Assembly

Diagnostic test kit manufacturers incorporate D-Luciferin Sodium Salt within in vitro diagnostics (IVDs) designed for highly sensitive viral, bacterial, and genetic marker detection using luciferase reporters. Cleanroom-grade blending, lyophilization or liquid filling practices ensure stable shelf-life and performance. The manufacturing process tightly controls moisture, contamination, and reagent purity to support long-term storage and consistent batch-to-batch assay reliability used in clinical laboratory environments.

Industry compliance standards

• IVD Directive 98/79/EC (for European market)
• EN ISO 23640 (Stability testing for IVD reagents)
• ISO 13485 Medical Devices QMS for consistent kit production
• Labeling and safety data sheet requirements per CLP Regulation (EC No 1272/2008)

Typical usage ratio

• 5–200 μg/mL in working reagent, defined by target assay type and detection sensitivity
• Ratio optimized to prevent signal saturation or false positives during actual test protocol

Downstream process integration

• Substrate blended into lyophilization mix or dosed into buffer prior to filling as component part of test kits
• Unit doses sealed in vacuum or nitrogen-purged vials according to process FMEA
• QC released following analytical purity, functional test, and contamination screen

Final product types

• Ready-to-use clinical bioluminescent IVD kits
• Real-time PCR and isothermal amplification detection reagent kits
• Single-use microfluidic diagnostic cartridges
• Laboratory developed test (LDT) bioluminescence substrate components

4. Environmental Water Quality Testing Reagents

Manufacturers utilize D-Luciferin Sodium Salt in reagent blends for rapid bioluminescent toxicity assays to assess water quality and pollutant presence. These kits measure the impact of contaminants on luciferase-expressing biosensor bacteria, facilitating municipal and industrial environmental monitoring. Processing requires chemical compatibility for various water matrices, reliable substrate stability under non-laboratory storage conditions, and robust light signal generation even after extended shipping or storage periods.

Industry compliance standards

• ISO 11348-3 Water quality – Determination of the inhibitory effect of water samples using Vibrio fischeri bioluminescence (Microplate test)
• US EPA Method 8013 (Screening for organic pollutants by bioluminescence)
• EN ISO 17025 (Test laboratory accreditation)
• Strength and labeling compliance for chemical reagent safety (OSHA Hazard Communication Standard)

Typical usage ratio

• 50–500 μg/mL in test well or reaction tube, scaled to amount of sample and test design
• Adjusted for organism type, water sample volume, and required detection limits

Downstream process integration

• Substrate prepared as part of test reagent mix and distributed in sealed, moisture-resistant packaging
• Reagent added during biosensor incubation phase before bioluminescence reading
• Field kits formulated for compatibility with portable luminometers and on-site testing

Final product types

• Rapid bioluminescent toxicity test kits for environmental labs
• Field-deployable water quality screening reagent packs
• Automated biosensor-based environmental pollution monitors
• Laboratory research reagents for aquatic toxicity screening

5. Agricultural Pathogen Detection Products

Agro-biotech companies develop bioluminescence assay kits using D-Luciferin Sodium Salt to detect phytopathogens and genetically modified organisms in crops and seeds. The substrate’s role is crucial during the downstream reaction amplification or visualization phase. Sourcing for this field demands agricultural-use documented traceability, and blending conditions must minimize plant matrix interference and environmental impact, with product storage and shipping stability validated for field and greenhouse deployment.

Industry compliance standards

• OECD Principles of Good Laboratory Practice
• ISO 16140-2 Validation of microbiological methods
• EPA and EU REACH Regulation (for agricultural test chemical import/export)
• ISO 9001 for manufacturing and supply chain traceability

Typical usage ratio

• 30–250 μg/mL, typically kept at lower range to minimize impact from plant-derived substrates and preserve signal specificity
• Ratio adjusted to crop type and sample extraction protocol

Downstream process integration

• Material incorporated into extraction or amplification reagent mixes for pathogen assays
• Added during detection phase post nucleic acid or protein amplification in crop sample testing
• Packed as either dry powder for on-site reconstitution or as a pre-mixed buffer reagent

Final product types

• On-site agricultural pathogenic screening kits
• Seed quality control bioluminescent test kits
• Plant health bioluminescent assay reagent sets
• High-throughput GMO traceability analysis kits